Connecticut is Home to Life Science Innovators & Researchers
Connecticut is a top destination for the Life Science industry. The state is home to a thriving life sciences community that is anchored by a robust ecosystem of cutting-edge research, highly educated workforce, and innovative companies.
From the artificial heart to stem cell study to genome research, Connecticut continues to demonstrate its commitment to serving as the center for biomedical advances. Connecticut has become a nucleus of life science advances—from groundbreaking research in personalized medicine to device manufacturing of the latest medical technology.
- #1 in Health IT adoption – a key indicator of healthcare innovation (Information Technology & Innovation Foundation)
- #2 in Bioscience R&D investments (TEConomy Partners)
- 2,500 life sciences companies call Connecticut home
- 39,000 people are employed in the industry
- #1 in healthcare access (U.S. News & World Report)
- 7th in the country in NIH funding per capita with $684M (National Institutes of Health)
- #3 in the U.S. for healthcare (U.S. News & World Report)
- #4 in Bioscience-related patents (U.S. Patent & Trademark Office)
- 80% of all Connecticut academic R&D investments are in bioscience
- #3 Managerial, Professional and Technical Jobs (Information Technology & Innovation Foundation)
- #2 in the nation patents per 1,000 individuals in science and engineering occupations. (National Science Foundation)
- 4th in the United States for Bioscience Venture Capital. (BioCT.org)
Support for Connecticut’s Life Sciences Industry
Connecticut has invested in the life sciences industry. There is support for this growing industry and resources designed to promote the research and development of new technologies, along with the continued cultivation of talent.
“Connecticut’s universities are great engines of innovation. Those ideas attract capital, both from the private sector and public sector. Together, with Connecticut’s talent pool, those are the three ingredients for a successful bioscience company.”
- Arvinas Founder Craig Crews on launching a pharmaceutical enterprise in New Haven
Connecticut Bioscience Innovation Fund (CBIF)
$204 million that provides up to $500,000 to help commercialize life sciences breakthroughs. $56.5M awarded to 97 projects.
R&D Tax Credit
Tax credit related to research and experimental expenditures conducted in Connecticut.
Angel Investment Tax Credit
Specific to angel investors with a cash investment of $25,000 or more.
Manufacturing and Biotechnology Sales and Use Tax Exemption
Sales tax exemptions for purchases or machinery, materials, tools and fuel used directly in the manufacturing production process. Also, for sales of the storage, machinery, equipment, tools, materials, supplies and fuel in the biotechnology industry.
Bioscience Enterprise Zone
For eligible businesses that have had more than 300 employees at any time during the preceding 12 months and are engaged in life sciences, biotechnology, pharmaceutical or photonics research, development or production in the state.
SBIR Acceleration and Commercialization program
The goal of the Small Business Innovation Research (SBIR) Acceleration and Commercialization program is to increase the participation of Connecticut-based firms in federal SBIR and STTR grant programs.
Bio Pipeline CT
The University of Connecticut, Yale University, and Quinnipiac University have joined forces with Connecticut Innovations and the Bioscience Innovation Fund to help you commercialize biomedical technology innovation (medical devices, diagnostics, and health information technology). This $1 million, two-year initiative provides up to $30,000 per project for much- needed gap funding to seedling companies or faculty and student groups associated with any Connecticut university.
Program in Innovative Therapeutics for Connecticut’s Health (PITCH)
Collaboration between Yale and UConn to help academic projects cross the Valley of Death between public and private sector development activities.
Network of services offered to entrepreneurs. Also offers Technology Talent Bridge Internship Program.
Programs and facilities to help grow the life sciences ecosystem. Includes Innovation Commons and Bioscience Clubhouse CT.
Yale University Center for Biomedical Innovation and Technology (CBIT)
Consortium of engineers, clinicians, scientists, innovators and entrepreneurs to help incubate, support, implement, and potentially bring to market novel technical approaches to address under-met clinical needs.
The Blavatnik Fund for Innovation at Yale
Supports Yale faculty in the commercialization of applied research and technology in life sciences. Pilot grants up to $100,000; development grants up to $300,000.
Public Act 18-147 Tax Deduction
For income generated by investments in eligible Connecticut-based life science businesses.
Next Generation Connecticut
Initiative to greatly expand educational opportunities, research, and innovation in the science, technology, engineering, and math (STEM) disciplines at UConn.